1. Latent profile analysis of cognitive decline and depressive symptoms after intracerebral hemorrhage
- Author
-
Sophia Keins, Jessica R. Abramson, Juan Pablo Castello, Marco Pasi, Andreas Charidimou, Christina Kourkoulis, Zora DiPucchio, Kristin Schwab, Christopher D. Anderson, M. Edip Gurol, Steven M. Greenberg, Jonathan Rosand, Anand Viswanathan, Alessandro Biffi, Massachusetts General Hospital [Boston], Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Lille, and Malbec, Odile
- Subjects
Depression ,Research ,[SDV]Life Sciences [q-bio] ,Cerebral small vessel disease ,General Medicine ,Magnetic Resonance Imaging ,nervous system diseases ,[SDV] Life Sciences [q-bio] ,Neuropsychiatric outcomes ,Cerebral Small Vessel Diseases ,Memory disorders ,Mood disorders ,Humans ,Cognitive Dysfunction ,Neurology. Diseases of the nervous system ,Neurology (clinical) ,cardiovascular diseases ,Intracerebral hemorrhage ,RC346-429 ,Cerebral Hemorrhage - Abstract
Background Cognitive impairment and depressive symptoms are highly prevalent after Intracerebral Hemorrhage (ICH). We leveraged Latent Profile Analysis (LPA) to identify profiles for cognitive decline and depression onset after ICH. We also investigated differences in clinical, genetic and neuroimaging characteristics across patients’ profiles. Methods We analyzed data from the ICH study conducted at Massachusetts General Hospital between January 1998 and December 2019. We collected information from electronical health records, follow-up interviews, CT and MRI imaging, and APOE genotype. We conducted LPA and multinomial logistic regression analyses to: 1) identify distinct profiles for cognitive decline and depression onset after ICH; 2) identify clinical, neuroimaging and genetic factors predicting individuals’ likelihood to express a specific profile. Results We followed 784 ICH survivors for a median of 45.8 months. We identified four distinct profiles in cognitive and depressive symptoms after ICH: low depression and dementia risk, early-onset depression and dementia, late-onset depression and dementia, high depression with low dementia risk. Cerebral small vessel disease severity and APOE genotype were specifically associated with the late-onset profile (both p < 0.05). Acute hematoma characteristics (size, intraventricular extension) and functional disability were specifically associated with the early-onset profile (all p < 0.05). Conclusion We identified four distinct profiles for cognitive and depressive symptoms after ICH, each displaying specific associations with individual patients’ clinical, genetic and neuroimaging data. These associations reflect separate biological mechanisms influencing dementia and depression risk after ICH. Our findings support employing LPA in future ICH studies, and is likely applicable to stroke survivors at large.
- Published
- 2021